Introduction
Preparation of 2,2,6,6-teramethyl-piperidin-4-one (triacetonamine) still attract researchers all over the world because of its importance and various applications [1] [2] [3] . 2,2,6,6-Tetramethyl-piperidine derivatives have different biological effects. 2,2,6,6-Tetramethyl-piperidine derivatives have anticancer, analgesic, antipyretic and anticholinergic effects [4, 5] . Also, 2,2,6,6-tetramethyl-piperidin-4-one have hypotensive and vasodilator activity as demonstrated by intravital microcirculation method [6] .
3,5-Bis(4-(dimethylamino) benzylidene)-2,2,6,6-tetramethylpiperidin-4-one (I), and 8-(4chlorobenzylidene)-4-(4-chlorophenyl)-5,5,7,7-tetramethyl-3,4,5,6,7,8-hexahydropyrido [4,3-d] pyrimidine-2(1H)-thione (II) have more anticancer activity against breast cancer cell lines than reference drug used in the study ( Fig. 1) [22] . 7-(4-Chlorobenzylidene)-3-(4-chlorophenyl)-4,4,6,6-tetramethyl-3,3a,4,5,6,7-hexahydro-2H-pyrazolo [4,3-c] pyridine-2-carbothioamide (III) and N-(7-(2-Chlorobenzylidene)-3-(2-chlorophenyl)-4,4,6,6-tetramethyl-3,3a,4,5,6,7-hexahydro-2H-pyrazolo [4,3-c] pyridine-2carbonothioyl)acetamide (IV) show high antitumor activity against hepatocellular carcinoma HepG2 cell lines [7] .
1-Hydroxy-2,2,6,6-tetramethylpiperidin-4-one derivatives are used as antioxidants [8] [9] [10] , contrast agents [11, 12] , spin probes [13] [14] [15] , spin labels [16, 17] , hindered amine light stabilizers [18] , nitroxide mediated redical polymerization agents [19, 20] .
Preperation of 1-hydroxy-2,2,6,6-tetramethylpiperidin-4-one (N-hydroxy-triacetonamine) starting from 2,2,6,6-tetramethylpiperidin-4-one was done through two steps (Scheme 1) [21] . The methods of preparation of 1-hydroxy-2,2,6,6-tetramethylpiperidin-4-one (N-hydroxytriacetonamine) which is mentioned in the literature are difficult and expensive, so we will report simple and one step method for its preparation (Scheme 1) [21] .
Also, reactions of N-hydroxytriacetonamine with various organic reagents will be reported.
Results and Discussion
2,2,6,6-Tetramethyl-4-piperidone contains different functions groups which could be used to react with various organic reagents. Active methylene adjacent to carbonyl group was used to prepare different chalcones which further react with different organic reagents [22] . In this article, we will prepare N-hydoxy derivative of triactonamine which will be the starting material. Although the oxygen of hydroxyl group linked to nitrogen in N-hydroxy-2,2,6,6-tetramethyl-4-piperidone (2) which is good electronegative atom, the oxygen atom of hydroxyl group is still a nucleophile which can react with different electrophiles.
2,2,6,6-Tetramethyl-4-piperidone (1) reacts with hydrogen peroxide in potassium hydroxide to afford N-hydroxy-2,2,6,6-tetramethyl-4-piperidone (2) (Scheme 1). N-Hydroxy-2,2,6,6-tetramethyl-4-piperidone (2) reacts with formaldehyde to give compound (3) which reacts with piperidine to affords compound (4) (Scheme 2). Compound (4) can be prepared directly by reacting N-hydroxy-2,2,6,6-tetramethyl-4-piperidone (2) with formaldehyde and piperidine (Scheme 2). Spectral data (IR, MS, shows disappearance of absorption band for hydroxyl group.
N-Hydroxy-2,2,6,6-tetramethyl-4-piperidone (2) reacts with sodium azide to afford 1-azido-2,2,6,6-tetramethylpiperidin-4-one (5) and 1-azido-2,2,7-trimethyl-1,4-diazepan-5-one (6). Although separation of compound (6) was done accidently, but it is expected. Ring expansion of piperidine derivative while reaction with sodium azide is reported [23] . The Infrared spectrum of compounds (5) and (6) show characteristic absorption band for azide group. Also, the IR spectrum of compound (6) show absorption band for carbonyl group of amide. The 1 H NMR of compound (6) shows signal for CH 2 N at δ 4.00.
N-Hydroxy-2,2,6,6-tetramethyl-4-piperidone (2) reacts with α-bromoacetoglucose and α-bromoacetoxylose to afford 2-(acetoxymethyl)-6-((2,2,6,6-tetramethyl-4-oxopiperidin-1-yl)oxy) tetrahydro-2H-pyran-3,4,5-triyl triacetate (7a) and 2-((2,2,6,6-tetramethy-4-oxopiperidin-1-yl) oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate (7b) respectively. Deacetylation of compounds (7a,b) were accomplished by ammonia solution to afford 2,2,6,6-tetramethyl-1-((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy) (2) 
Antimicrobial activity
The antimicrobial activity of new compounds was done according to reported procedure [24] . Antimicrobial screening of some of the synthesized compounds is summarized in the following table (Table 1) . Most of tested compounds show moderate activity against reference drug. Compound (5) shows highest antibacterial activity against reference drug cefotaxime. Also, compound (10a) shows highest antifungal activity against reference drug nystatin. 
Experimental
All melting points are uncorrected and measured using Electro-thermal IA 9100 apparatus (Shimadzu, Tokyo, Japan). IR spectra were recorded as potassium bromide pellets on a PerkinElmer 1650 spectrophotometer (Perkin-Elmer, Norwalk, CT, USA).
1 H NMR was determined on a Jeol-Ex-400 NMR spectrometer (Jeol, Tokyo, Japan) and chemical shifts were expressed as part per million; ppm (δ values) against TMS as internal standard. Mass spectra were recorded on VG 2AM-3F mass spectrometer (Thermo electron corporation, USA). Microanalyses were operated using Mario El Mentar apparatus and satisfactory results were within the accepted range (±0.30) of the calculated values. Follow up the reactions and checking the purity of the compounds was made by TLC on silica gel-protected aluminium sheets (Type 60 F254, Merck). Mass spectra, and elemental analysis were done in Microanalytical Centre in Faculty of Science, Cairo University. C NMR, IR spectra, and antimicrobial activity were done in National Research Centre, Cairo, Egypt. All used chemicals were of reagent grade and were used as supplied directly unless otherwise stated.
1-Hydroxy-2,2,6,6-tetramethylpiperidin-4-one (2)
Triacetonamine 1 ( 
-( H y d r o x y m e t h o x y ) -2 , 2 , 6 , 6 -tetramethylpiperidin-4-one (3)
A mixture of compound 2 (0.01 mole), and formaldehyde (0.01 mole) is heated under reflux with stirring in 50 ml absolute ethanol for 1 hour. The reaction mixture is evaporated under reduced pressure to give solid residue. 
2,2,6,6-Tetramethyl-1-(piperidin-1-ylmethoxy) piperidin-4-one (4)
Method A A mixture of compound 3 (0.01 mole), piperidine (0.01 mole) is refluxed in 50 mL absolute ethanol under TLC control. The reaction mixture is evaporated under reduced pressure. The residue collected crystallized from ethanol to give compound 4 (yield 61 %). IR (KBr, cm 
95-97
o C). (5) and (6) Compound 2 (0.01 mole) is refluxed with sodium azide (0.01 mole) in 5 mL acetic acid and 4 drops of water for 15 minutes. The precipitate formed is filtered, dried and crystallized from benzene to afford compound 5. The filterate is evaporated under reduced pressure to produce compound 6.
Preparation of compounds

1-Azido-2,2,6,6-tetramethylpiperidin-4-one (5)
Yield 73%, m.p. 
1-Azido-2,2,7-trimethyl-1,4-diazepan-5-one(6)
Yield 10 %, m.p. 2,3,4,6-Tetra-O-acetyl-α-D-glucopyranosyl bromide or 2-hydroxytetrahydro-2H-pyran-3,4,5-triyl triacetate (0.005 mole) dissolved in acetone (15 mL) was added portion-wise to a clear solution of compound 2 (0.005 mole) and potassium hydroxide (0.28g, 0.005 mole) in distilled water (2 ml). The reaction mixture was stirred at room temperature until reaction was judged complete by TLC(pet. ether/ethyl acetate, 4:1 v/v). Evaporation of the solventafforded a residue which was washed with distilled water (10 mL) followed by extraction with chloroform. The obtained residue after removal of chloroform was triturated with petroleum ether (b.p. 40-60 °C) (45 mL) with stirring. The solid product was filtered, dried and recrystallized from ethanol to produce compound 7a,b.
2-(Acetoxymethyl)-6-((2,2,6,6-tetramethyl-4-oxopiperidin-1-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate(7a)
IR (KBr, cm -1 ) ν: 1709 (C=O), 1742 (C=O). MS, m/z (%) 501 (M+, 31% 2,2,6,6-tetramethyl-4-oxopiperidin-1-yl) 
2-((
General method for preparation of compounds (8a,b)
The acetylated glycosides 7a,b (5 mmol) was dissolved in dry saturated methanolic ammonia solution (20 mL) and stirred at 0 °C for 1 h, then stirring was persisted at r.t. for 5 h. Removal of the solvent under vacuum at 40 °C gave a solid residue, which was recrystallized from ethanol to give the corresponding free glycoside 8a,b.
2,2,6,6-tetramethyl-1-((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy) piperidin-4-one(8a)
IR (KBr, cm 
2,2,6,6-t e t r a m e t h y l-1-((3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)piperidin-4-one(8b)
IR ( 
2-Amino-3-carbamoyl-8-(4-chlorobenzylidene)-4-(4-chlorophenyl)-5,5,7,7-tetramethyl-7,8-dihydro-1,6-naphthyridin-6(5H)-yl acetate(10a)
Compound 2 (0.01 mole) is heated under reflux for 4 hours with p-chlorobenzaldehyde (0.02 mole) and cyanoacetamide (0.01 mole) in ammonium acetate (1 g.) and acetic acid (10 mL -5,5,7,7-tetramethyl-5,6,7,8-tetrahydro-1,6-naphthyridine-3-carboxylate (10b) Compound 2 (0.01 mole) is heated under reflux for 4 hours with p-chlorobenzaldehyde (0.02 mole) and ethylcyanoacetate (0.01 mole) in ammonium acetate (1 g.) and acetic acid (10 mL 
E t h y l -6 -a c e t o x y -2 -a m i n o -8 -( 4 -chlorobenzylidene)-4-(4-chlorophenyl)
